<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Toxicol Res (Camb)</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicol Res (Camb)</journal-id>
<journal-title-group>
<journal-title>Toxicology Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">2045-452X</issn>
<issn pub-type="epub">2045-4538</issn>
<publisher>
<publisher-name>Royal Society of Chemistry</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30090610</article-id>
<article-id pub-id-type="pmc">6062062</article-id>
<article-id pub-id-type="publisher-id">c7tx00317j</article-id>
<article-id pub-id-type="doi">10.1039/c7tx00317j</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromatin dynamics underlying latent responses to xenobiotics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Moggs</surname>
<given-names>Jonathan</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2393-6624</contrib-id>
<xref ref-type="aff" rid="affa">a</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Terranova</surname>
<given-names>Rémi</given-names>
</name>
<xref ref-type="aff" rid="affa">a</xref>
</contrib>
</contrib-group>
<aff id="affa"><label>a</label>
Preclinical Safety
, Translational Medicine
, Novartis Institutes for BioMedical Research
,
Basel
, Switzerland
</aff>
<pub-date pub-type="epub">
<day>28</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<day>1</day>
<month>7</month>
<year>2018</year>
</pub-date>
<volume>7</volume>
<issue>4</issue>
<fpage>606</fpage>
<lpage>617</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>This journal is © The Royal Society of Chemistry 2018</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract abstract-type="toc">
<p>
<graphic id="ga" orientation="portrait" position="float" xlink:href="c7tx00317j-ga.jpg"></graphic>Xenobiotic-induced perturbations of somatic tissue or germline epigenomes may underlie delayed-onset and long-lasting adverse effects.</p>
</abstract>
<abstract>
<p>Pleiotropic xenobiotics can trigger dynamic alterations in mammalian chromatin structure and function but many of these are likely non-adverse and simply reflect short-term changes in DNA transactions underlying normal homeostatic, adaptive and protective cellular responses. However, it is plausible that a subset of xenobiotic-induced perturbations of somatic tissue or germline epigenomes result in delayed-onset and long-lasting adverse effects, in particular if they occur during critical stages of growth and development. These could include reprogramming, dedifferentiation, uncontrolled growth, and cumulative toxicity effects through molecular memory of prior xenobiotic exposures or altered susceptibility to subsequent xenobiotic exposures. Here we discuss the current evidence for epigenetic mechanisms underlying latent responses to xenobiotics, and the potential for identifying molecular epigenetic changes that are prodromal to overt morphologic or functional toxicity phenotypes.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>